Our team is frequently featured in national journals and news networks —check out the articles below to learn more: Michael Bolton diagnosed with brain cancer glioblastoma. What is that? May 8, 2025 Lab In The news Signal Alert: Startup Seeks Community Funders for AAV Immuno-Gene Therapy May 8, 2025 Lab In The news Integrated Proteogenomic Characterization of Glioblastoma Evolution: Overcoming Barriers to Develop Personalized Treatment Strategies May 8, 2025 Lab In The news Uncategorized Injection Immunotherapies Get FDA Approval May 8, 2025 Lab In The news New study highlights telehealth struggles in cancer care May 8, 2025 Lab In The news Clinical Trials Are Moving Out of the Lab and Into People’s Homes May 8, 2025 Lab In The news Uncategorized Michael Bolton Brain Cancer: What Is Glioblastoma, What Are the Symptoms and Can You Prevent It? May 8, 2025 Lab In The news Experimental therapy for brain cancer gives ‘hope’; will be investigated in upcoming trial May 12, 2025 Lab In The news Uncategorized The Khasraw Lab in Duke Health News Q&A: PuMP Trial for Recurrent Glioblastoma May 12, 2025 DUKE HEALTH PuMP: Oncolytic HSV1 MVR-C5252 in Patients with rHGG (Recurrent Glioma) May 12, 2025 DUKE HEALTH Q&A: The MOAB Trial – Now Enrolling. Click to learn more! May 12, 2025 DUKE HEALTH Uncategorized Evaluation of fluoxetine (Prozac) and Cytotoxic Lysosomal Stress in Glioma (FLIrT) May 12, 2025 DUKE HEALTH Analysis Details Lasting Effects of the Covid-19 Pandemic on Cancer Care May 12, 2025 DUKE HEALTH Mustafa Khasraw to Lead U.S. Arm of International Glioblastoma Trial May 12, 2025 DUKE HEALTH Uncategorized
